Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit	Treasury Stock
Beginning of period (in shares) at Jan. 31, 2023		122,335,000
Beginning of period at Jan. 31, 2023	$ 128,023	$ 142	$ 897,368	$ (3,617)	$ (676,542)	$ (89,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		1,704,000
Exercise of stock options	9,378	$ 2	9,376
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares)		2,952,000
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes	(13,014)	$ 3	(13,017)
Issuance of restricted stock (in shares)		75,000
Issuance of common stock under employee stock purchase plan (in shares)		782,000
Issuance of common stock under employee stock purchase plan	3,672	$ 1	3,671
Stock-based compensation	45,224		45,224
Repurchase of common stock (in shares)		(2,981,000)
Repurchase of common stock	(22,913)					(22,913)
Other comprehensive (loss) income	(566)			(566)
Net income (loss)	(2,630)				(2,630)
End of period (in shares) at Jan. 31, 2024		124,867,000
End of period at Jan. 31, 2024	147,174	$ 148	942,622	(4,183)	(679,172)	(112,241)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		367,000
Exercise of stock options	1,291	$ 1	1,290
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares)		3,509,000
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes	(3,185)	$ 4	(3,189)
Issuance of restricted stock (in shares)		138,000
Issuance of common stock under employee stock purchase plan (in shares)		805,000
Issuance of common stock under employee stock purchase plan	3,689		3,689
Stock-based compensation	52,065		52,065
Repurchase of common stock (in shares)		(2,687,000)
Repurchase of common stock	(18,107)					(18,107)
Other comprehensive (loss) income	(1,786)			(1,786)
Net income (loss)	$ (27,948)				(27,948)
End of period (in shares) at Jan. 31, 2025	126,999,461	126,999,000
End of period at Jan. 31, 2025	$ 153,193	$ 153	996,477	(5,969)	(707,120)	(130,348)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	341,553	341,000
Exercise of stock options	$ 2,154		2,154
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares)		4,339,000
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes	(23,010)	$ 4	(23,014)
Issuance of restricted stock (in shares)		67,000
Issuance of common stock under employee stock purchase plan (in shares)		605,000
Issuance of common stock under employee stock purchase plan	3,167	$ 1	3,166
Stock-based compensation	49,117		49,117
Repurchase of common stock (in shares)		(9,418,000)
Repurchase of common stock	(67,471)					(67,471)
Other comprehensive (loss) income	4,400			4,400
Net income (loss)	$ 37,871				37,871
End of period (in shares) at Jan. 31, 2026	122,933,027	122,933,000
End of period at Jan. 31, 2026	$ 159,421	$ 158	$ 1,027,900	$ (1,569)	$ (669,249)	$ (197,819)